Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/1156
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
VIDEX EC (Capsule, Delayed Release)
|
| dailymed-instance:activeIng... | |
| dailymed-instance:genericDr... | |
| dailymed-instance:boxedWarn... |
WARNING: PANCREATITIS, LACTIC ACIDOSIS and HEPATOMEGALY with STEATOSIS: Fatal and nonfatal pancreatitis
has occurred during therapy with didanosine used alone or in combination regimens
in both treatment-naive and treatment-experienced patients, regardless of
degree of immunosuppression. VIDEX EC should be suspended in patients with
suspected pancreatitis and discontinued in patients with confirmed pancreatitis
[see Warnings and Precautions (5.1)]. Lactic
acidosis and severe hepatomegaly with steatosis, including fatal cases, have
been reported with the use of nucleoside analogues alone or in combination,
including didanosine and other antiretrovirals. Fatal lactic acidosis has
been reported in pregnant women who received the combination of didanosine
and stavudine with other antiretroviral agents. The combination of didanosine
and stavudine should be used with caution during pregnancy and is recommended
only if the potential benefit clearly outweighs the potential risk [see
Warnings and Precautions (5.2)].
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... |
dailymed-ingredient:carboxymethylcellulose_sodium_12,
dailymed-ingredient:diethyl_phthalate,
dailymed-ingredient:edible_ink_(green),
dailymed-ingredient:gelatin,
dailymed-ingredient:methacrylic_acid_copolymer,
dailymed-ingredient:sodium_hydroxide,
dailymed-ingredient:sodium_starch_glycolate,
dailymed-ingredient:talc,
dailymed-ingredient:titanium_dioxide
|
| dailymed-instance:genericMe... |
didanosine
|
| dailymed-instance:fullName |
VIDEX EC (Capsule, Delayed Release)
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
VIDEX EC
|